A randomized, double-blind, placebo-controlled study of risperidone monotherapy in ambulatory bipolar disorder with current at least moderately severe anxiety and lifetime panic disorder or generalized anxiety disorder.
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Risperidone (Primary)
- Indications Anxiety disorders; Bipolar disorders
- Focus Therapeutic Use
- 20 Nov 2005 New trial record.